Project 002 - VIDI
Project 002 - VIDI
批准号:
10459875
负责人:
Sara Gianella Weibel
金额:
$33.18万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-01 至 2027-03-31
关键词:
AntigensArchitectureAreaBiological AssayBloodCCR6 geneCD4 Positive T LymphocytesCellsCessation of lifeChromatinClonal ExpansionData AnalysesData SetDetectionEffector CellEnvironmentEnvironmental Risk FactorEpigenetic ProcessFamilyFire - disastersGenesGenetic TranscriptionGenomeGiftsGoalsHIVHIV InfectionsHomeHuman bodyImageImaging technologyImmuneImmunologyInflammationIntegration Host FactorsInterruptionIntrinsic factorInvestigationKnowledgeLymphoid TissueMicroscopyMilieu TherapyMucous MembraneNatural Killer CellsPenetrationPersonsPharmaceutical PreparationsPharmacologyPhasePhenotypePlasmaPopulation DynamicsPopulation ProcessProcessProvirusesResearch Project GrantsResourcesRunningSamplingScienceSeedsShockSiteSourceSpecimenSurfaceTechniquesTechnologyTissuesViralViral PhysiologyViremiaVirusadaptive learningantiretroviral therapybrain tractcellular imagingcohortcomorbidityend of lifehigh dimensionalityimprovedin vivoinflammatory milieuinnovationinsightinterestprogrammed cell death protein 1programsreproductive tractsingle cell technologysocial stigmasuccesstherapeutic targetviral rebound
中文摘要
项目2。病毒免疫学,药物和成像(VIDI)研究项目-摘要
英文摘要
PROJECT 2. Viral Immunology, Drugs, and Imaging (VIDI) Research Project - ABSTRACT
Despite the success of antiretroviral therapy (ART) improving the lives of persons with HIV (PWH), curing HIV
would be important to reduce stigma and long-term co-morbidities associated with HIV infection that occur even
during ART. Developing a successful cure will need to better identify the viral and host factors that govern HIV
dynamics in its HIV Obligate MicroEnvironment (HOME) to identify reservoir vulnerabilities that can be targeted.
The Viral Immunology, Drugs, and Imaging (VIDI) Research Project (RP) will focus on immune, pharmacological,
host epigenetic cellular environments, and tissue architecture that govern the continuum of HIV reservoir
dynamics. This characterization by the VIDI RP alone will add considerable new knowledge to the field. In the
HOME program, these assay results will be integrated with viral features of HIV reservoir dynamics characterized
by VENI RP, and all datasets will be further integrated and analyzed by VICI RP.
For experimental planning, the HIV reservoir dynamic continuum is simplified as the following reservoir states:
· Leaves HOME when HIV (re)activates from tissues during antiretroviral therapy (ART) (i.e., like packing its
bag and getting ready to leave) and causes rebound viremia during ART interruption.
· Comes HOME when HIV (re)populates tissues during viremia off ART and through the spread of clonally
expanded HIV-infected cells while on ART. (Clonal expansion is like adding family to the home.)
· Stays HOME when HIV (silently) persists in blood and tissue reservoirs (on and off ART).
To optimize allocated resources, we developed a two-step Adaptive Learning Approach. During the Mapping
phase, the VIDI RP will examine how cellular and soluble inflammatory milieus and ART levels are associated
with each reservoir state (i.e., leaving, coming, staying). The VICI RP will assist in the integration and analysis
of these data to identify ‘samples-of-interest’ that have pre-defined reservoir states and sufficient cellular
environment for deeper investigation. In the Confirmation phase, the VIDI RP will use single-cell and imaging
technologies to further characterize environmental factors associated with reservoir dynamics at a deeper level.
Importantly, the feasibility of our VIDI RP is greatly enhanced by the knowledge gained from our previous P01
(AI131385) and its Last Gift Cohort, which collects pre- and post- mortem specimens from PWH who did (n=5)
or did not stop ART (n=15) before death. The HOME program will allow the continuation of this cohort while
expanding the science to study HIV dynamics across the human body at the single-genome and single-cell level.
In summary, the overall HOME program will provide a deep delineation of environmental factors governing HIV
reservoir dynamics, which is directly responsive to the Understanding HIV Reservoir Dynamics RFA AI-21-013.
This new knowledge will inform HIV cure strategies aiming at reversing latency (“Shock and Kill”) or at silencing
permanently deep reservoirs (“Block and Lock”) and provide new insights in ways to reduce local HIV-associated
tissue damage, which has been implicated in inflammation-related illnesses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sex-differences in HIV persistence and Immune Dynamics during Reproductive Aging
-
批准号:10838316
-
项目类别:
-
资助金额:$83.95万
-
财政年份:2023
-
负责人:Sara Gianella Weibel
-
依托单位:
Project 002 - VIDI
-
批准号:10602744
-
项目类别:
-
资助金额:$67.56万
-
财政年份:2022
-
负责人:Sara Gianella Weibel
-
依托单位:
Impact of Reproductive Aging On HIV Persistence and Inflammation
-
批准号:10433074
-
项目类别:
-
资助金额:$84.26万
-
财政年份:2021
-
负责人:Sara Gianella Weibel
-
依托单位:
Core K: Translational Virology
-
批准号:9906067
-
项目类别:
-
资助金额:$34.99万
-
财政年份:2020
-
负责人:Sara Gianella Weibel
-
依托单位:
Mechanisms of CMV Replication on HIV Persistence
-
批准号:10012877
-
项目类别:
-
资助金额:$80.44万
-
财政年份:2020
-
负责人:Sara Gianella Weibel
-
依托单位:
The HIV-associated Opioid Micro-Environment (HOME) Project
-
批准号:10056153
-
项目类别:
-
资助金额:$236.81万
-
财政年份:2020
-
负责人:Sara Gianella Weibel
-
依托单位:
Mechanisms of CMV Replication on HIV Persistence
-
批准号:10241944
-
项目类别:
-
资助金额:$80.16万
-
财政年份:2020
-
负责人:Sara Gianella Weibel
-
依托单位:
Mechanisms of CMV Replication on HIV Persistence
-
批准号:10448351
-
项目类别:
-
资助金额:$82.32万
-
财政年份:2020
-
负责人:Sara Gianella Weibel
-
依托单位:
Effect of Declining Sex Hormones on HIV persistence in HIV Infected Women on ART
-
批准号:9568360
-
项目类别:
-
资助金额:$19.71万
-
财政年份:2017
-
负责人:Sara Gianella Weibel
-
依托单位:
Effect of Declining Sex Hormones on HIV persistence in HIV Infected Women on ART
-
批准号:9482258
-
项目类别:
-
资助金额:$24.41万
-
财政年份:2017
-
负责人:Sara Gianella Weibel
-
依托单位:
NeuroVirology & Biology Core
-
批准号:10561658
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2001
-
负责人:Sara Gianella Weibel
-
依托单位:
NeuroVirology & Biology Core
-
批准号:10380799
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2001
-
负责人:Sara Gianella Weibel
-
依托单位:
NeuroVirology & Biology Core
-
批准号:10261755
-
项目类别:
-
资助金额:$20.04万
-
财政年份:2001
-
负责人:Sara Gianella Weibel
-
依托单位:
Core K: Translational Virology
-
批准号:10671346
-
项目类别:
-
资助金额:$37.05万
-
财政年份:1997
-
负责人:Sara Gianella Weibel
-
依托单位:
HOPE Training Grant
-
批准号:10327160
-
项目类别:
-
资助金额:$47.72万
-
财政年份:1990
-
负责人:Sara Gianella Weibel
-
依托单位:
HOPE Training Grant
-
批准号:10491923
-
项目类别:
-
资助金额:$41.31万
-
财政年份:1990
-
负责人:Sara Gianella Weibel
-
依托单位:
HOPE Training Grant
-
批准号:10656517
-
项目类别:
-
资助金额:$46.1万
-
财政年份:1990
-
负责人:Sara Gianella Weibel
-
依托单位:
海外基金